公司資料
Simulations Plus 股價、新聞與催化劑
- 股票代碼:
- SLP
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
18.40 USD (0.00%)
收盤價
最後更新: 2026年8月24日
339M USD
市值
股價為何變動
As of Aug 24, 2026, SLP was little changed and closed at $18.40. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Simulations Plus is a software company that provides modeling, simulation, and workflow tools for drug development. Its value lies in helping biopharma customers make better development decisions.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Simulations Plus sits in pharma software and development tools.
商業模式特徵
The company depends on software subscriptions, services, and continued adoption by drug developers and regulators.
生技產業定位
Simulations Plus is an important biotech-enabling software name, not a drug company itself.
未來催化劑
- Simulations Plus's catalysts are software bookings, biosimulation demand, and AI-driven workflow adoption in pharma development. Investors will want to see whether the modeling platform stays embedded in drug development workflows.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。